Tenders/Aflibercept 40mg/1ml (in pre-filled syringe) for intravitreal administration

Open🇧🇪BelgiumSupplies

Aflibercept 40mg/1ml (in pre-filled syringe) for intravitreal administration

Auto-translated from Dutch

Original title: Aflibercept 40mg/1ml (in voorgevulde spuit) voor intravitreale toediening

Universitair Ziekenhuis Brussel

Published: Oct 14, 2026

Updated: Oct 16, 2026

Source: Belgium e-Procurement

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums.

Published through Belgium e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Dutch

This tender, originating from Belgium and published on the belgium_eprocurement platform, is for the supply of Aflibercept 40mg/1ml, specifically in a pre-filled syringe for intravitreal administration. The reference to 'Zie bestek' indicates that detailed specifications and requirements are provided within the official tender documentation. Aflibercept is a pharmaceutical agent used in ophthalmology to treat conditions such as wet age-related macular degeneration and diabetic macular oedema. The contracting authority, likely a healthcare provider or public health body in Belgium, is seeking a reliable supply of this critical medication. Key requirements for bidders will include demonstrating the ability to supply authentic, high-quality Aflibercept that meets all relevant pharmaceutical manufacturing standards (e.g., GMP) and regulatory approvals (e.g., EMA). The tender will likely specify packaging requirements, shelf-life expectations, and delivery logistics to ensure the integrity of the product. Furthermore, suppliers may need to provide evidence of regulatory compliance, pharmacovigilance capabilities, and a stable supply chain to meet the ongoing clinical needs of patients requiring this treatment.

Data provenance

This notice is sourced from Belgium e-Procurement and was originally published on October 14, 2026. Last refreshed today. Original language: Dutch. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Universitair Ziekenhuis Brussel

Universitair Ziekenhuis Brussel has issued 24 procurement notices on BidsFactory, including 3 currently open and 5 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: October 14, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Belgium e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Universitair Ziekenhuis Brussel in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.